IP Verse

Identifying Patient Response To S1p Receptor Modulator Administration - EP3647783

PATENT ANALYSIS

Patent Details

Grant Date
Dec 21, 2022
Company
NOVARTIS AG
Oppositions

KILBURN & STRODE LLP

KRAUS & LEDERER PARTGMBB

SYNTHON BV

VENNER SHIPLEY LLP

More patents of Novartis Ag

EP3124018

EP3023095

EP3626270

Want to monitor this patent?

Feel free to send us a message here and we will get back to you